These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1747706)

  • 1. Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives.
    Julkunen H; Kaaja R; Jouhikainen T; Teppo AM; Friman C
    Br J Rheumatol; 1991 Dec; 30(6):471-2. PubMed ID: 1747706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.
    Julkunen HA
    Scand J Rheumatol; 1991; 20(6):427-33. PubMed ID: 1771400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
    Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and neurologic complications in malignant hypertension due to oral contraceptive use.
    Bortolotto LA; Silva HB; Pileggi F
    Blood Press; 1994 Sep; 3(5):319-21. PubMed ID: 7866596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary complications of oral contraceptives.
    Lindberg MC
    J Gen Intern Med; 1992; 7(2):199-209. PubMed ID: 1336797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report.
    Miller MH
    Ann Rheum Dis; 1987 Feb; 46(2):159-61. PubMed ID: 3827339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL; Hughes GR
    J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive practice in women with systemic lupus erythematosus.
    Julkunen HA; Kaaja R; Friman C
    Br J Rheumatol; 1993 Mar; 32(3):227-30. PubMed ID: 8448613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein thrombosis associated with prolonged ingestion of oral contraceptive steroids.
    Chu G; Farrell GC
    J Gastroenterol Hepatol; 1993; 8(4):390-3. PubMed ID: 8374097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill.
    Todd GR; McAteer EJ; Jack CM; Haire M; Roberts SD; Buchanan KD
    Ann Rheum Dis; 1985 Apr; 44(4):266-7. PubMed ID: 3985693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraception in older woman.
    Volpe A; Silferi M; Genazzani AD; Genazzani AR
    Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of systemic lupus erythematosus after taking oral contraceptives].
    Kawai T; Katoh K; Matsunaga K; Tani K; Okubo T
    Nihon Naika Gakkai Zasshi; 1989 May; 78(5):710-1. PubMed ID: 2768993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and systemic lupus erythematosus.
    Garovich M; Agudelo C; Pisko E
    Arthritis Rheum; 1980 Dec; 23(12):1396-8. PubMed ID: 7458971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.